A 72-year-old man is admitted with a non-ST elevation myocardial infarction. Coronary angiography shows multi-vessel coronary artery disease managed medically without stenting. He has no major bleeding risk factors and normal renal function. He is already taking aspirin 100 mg daily. Which antithrombotic regimen is most appropriate for secondary prevention over the next 12 months?